Phycobilins are disclosed to have prodrug activity as inhibitors of NADPH oxidase activity and are disclosed to be useful in the prophylaxis and/or treatment of medical conditions associated with or linked to an NADPH oxidase activity. Compositions containing phycobilins are described which facilitate the administration of phycobilins.
申请公布号
EP2091530(A4)
申请公布日期
2010.08.04
申请号
EP20070862004
申请日期
2007.11.13
申请人
MCCARTY, MARK FREDRICK;HENDLER, SHELDON SAUL;RORVIK, DAVID MICHAEL;INOGUCHI, TOYOSHI
发明人
MCCARTY, MARK FREDRICK;HENDLER, SHELDON SAUL;RORVIK, DAVID MICHAEL;INOGUCHI, TOYOSHI
